Advertisement

Topics

A1M Pharma Company Profile

22:01 EDT 23rd March 2017 | BioPortfolio

A1M Pharma develops a diagnostic method and a novel treatment for the damaging effects of pre-eclampsia, a condition that affects around 10 million pregnant women worldwide. This disorder is responsible for 76,000 maternal and 500,000 infant deaths each year. It is also the cause of 15 per cent of all premature births. Currently, there is no predictive diagnostic method or treatment for impairments to kidney function associated with pre-eclampsia. In serious cases, doctors are forced to terminate the pregnancy which leads to premature infants and results in a substantial health care cost burden. Several preclinical studies indicate that A1M Pharma’s candidate drug, ROSGard™, based on the endogenous protein alpha-1-microglobulin, restores impairments to kidney function by repairing damaged tissue and protecting against oxidative stress. Kidney injury is a condition which is often associated with major surgery and with cancer treatments using radiation therapies. The company is therefore also developing a treatment for these acute kidney injuries. The first indication is kidney protection in connection with PRRT – a targeted radiation therapy for cancer – with the aim of opening the possibility of increasing treatment levels and so fight the cancer more effectively. Every year, over 12 million people are affected by acute kidney injuries that can lead to permanent kidney damage.

Location

Scheelevägen 22
Lund
223 63
Sweden

Contact

Phone: +46 46 286 50 30


News Articles [1009 Associated News Articles listed on BioPortfolio]

VERONA PHARMA PLC - Issue of Equity

PR NewswireLondon, December 29 Verona Pharma plc ("Verona Pharma" or the "Company") Exercise of Options Verona Pharma plc (AIM: VRP), the drug development company focused on first-in-class medicin...

NASDAQ OMX Nordic: Derivatives: Anticipated adjustment in Karo Pharma due to rights issue (02/17)

The following information is based on a press release from Karo Pharma AB (Karo Pharma) published on January 16, 2017 and may be subject to change. The board of Karo Pharma has proposed that the Ex...

Tetra Bio-Pharma Inc. Announces a New Appointment to its Scientific and Clinical Advisory Board

OTTAWA, ONTARIO -- (Marketwired) -- 01/11/17 -- PhytoPain Pharma Inc. ("PhytoPain Pharma" or "PPP"), a subsidiary of Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (CSE: TBP)(CSE: TBP.CN)(OTC PI...

Mezzion hires Pol Pharma and Halo Pharma and accuses Dr Reddy's of fraud

Mezzion has hired Pol Pharma and Halo Pharma and accused former CMO Dr Reddy’s of hiding manufacturing problems that cost its erectile dysfunction candidate, udenafil, US approval.

Top 32 Pharma companies: Perception of Pharma Companies Pairing of the Most Admired Pharma Companies – A Survey by eyeforpharma, its mission is to make Pharma companies more open and valued

Top 32 Pharma companies: Perception of Pharma Companies Pairing of the Most Admired Pharma Companies – A Survey by eyeforpharma, its mission is to make Pharma companies more open and valued R...

Roche: Big Pharma statet großes Comeback

Betrachtet man die Kurse der großen Pharma-Unternehmen in den letzten Monaten, wurde der Wahlsieg von Hillary Clinton schon vorweggenommen und eingepreist. Doch - es kam alles anders und die Pharma.....

Big Pharma Outlook 2025, An Infographic

Big Pharma is poised for growth because of strong launch portfolios, the availability of high-potential pipeline assets, and a focus...    

We promise that it is still worthwhile to file pharma patents in Canada

The “promise doctrine” is getting a lot of press in the pharma industry. We know that some big pharma companies are ticked off, for example, from Eli Lilly launching a NAFTA claim against the Cana...

Drugs and Medications [238 Associated Drugs and Medications listed on BioPortfolio]

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 0.5 mg

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 1 mg

Metoprolol tartrate [Med-Health Pharma, LLC]

Metoprolol Tartrate Tablets, USP

Urea [Libertas Pharma, Inc.]

Rx Only 45% Urea Nail Gel In a vehicle containing Camphor, Eucalyptus Oil and Menthol )

Eloxatin [Aventis Pharma Ltd.]

PubMed Articles [18 Associated PubMed Articles listed on BioPortfolio]

The moderating role of absorptive capacity and the differential effects of acquisitions and alliances on Big Pharma firms' innovation performance.

In the context of increased pharmaceutical innovation deficits and Big Pharma blockbusters' patent expirations, this paper examines the moderating role of firms' absorptive capacity in external innova...

Scratching the Career Itch Leads To Bigger Reach in Pharma.

A Review of "Big Pharma, Women, and the Labour of Love"by Thea Cacchioni. Toronto, Canada: University of Toronto Press, 2015, 167 pages, $50.00 (hardcover), $21.95 (paperback), $20.85 (Kindle).

AMCP Seeks an End to 20 Years Of Confusion Over FDAMA Section 114.

The FDA never issued regulations to clarify the boundaries of promotion of pharmacoeconomic data, something it's been dragging its feet on for nearly 20 years. In turn, pharma companies, fearful of be...

▼Pitolisant for narcolepsy.

▼Pitolisant (Wakix-Bioprojet Pharma) is a new treatment for adults with narcolepsy with or without cataplexy. It was licensed for use in the EU in March last year and has orphan drug status.(1) Here...

Clinical Trials [71 Associated Clinical Trials listed on BioPortfolio]

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.

A Bioequivalence Study of Cefadroxil From Duricef 1 gm F.C.T (GSK) and Biodroxil 1 gm F.C.T (Novartis Pharma)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Cefadroxil from Duricef 1 gm Film Coated tablets(Smthkline Beecham Egypt,LLC aff...

Pharma-Pen (Formerly Innoject) Auto-Injectory TIV

The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...

A Bio-equivalence Study of Sofosbuvir From Sofodelevier 400 mg Film Coated Tablets (Al-debeiky Pharma, Egypt) Versus Sovaldi 400 mg Tablets (Gilead Sciences, Canada)

Comparative randomized, single dose, three way three sequence two treatment partial replicate crossover open-label study to determine the bioequivalence of Sofosbuvir from Sofodelevier 400...

A Bioequivalence Study of Dexlansoprazole From Doxirazole 60 mg Capsules (Hikma Pharma,Egypt)and Dexilant 60 mg Delayed Release (DR) Capsules (Takeda Pharmaceuticals America Inc., USA)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Dexlansoprazole from Doxirazole 60 mg Capsules (Hikma Pharma,Egypt)and Dexilant...

Companies [698 Associated Companies listed on BioPortfolio]

H3 Pharma Incorporated

H3 Pharma Inc. is a Venture Pharma focusing on the development of human therapeutic products oriented towards age-related disorders. At H3 Pharma, we aim to be the best at identifying, evaluating and ...

LEO Pharma Inc.

LEO Pharma Inc. is headquartered in Parsippany, New Jersey, and is the U.S. affiliate of Denmark-based LEO Pharma A/S, a global leader in dermatology and critical care with more t...

Laurantis Pharma Oy

Laurantis Pharma Oy is a privately held specialty pharmaceutical company based in Finland. Laurantis Pharma Oy was formed in 2010 through the merger of two independent companies, ...

FranceMed Pharma

FranceMed Pharma is a Research, Development, FMCG Manufacturer and Global Marketing Company established since 1981. FranceMed Pharma owns Magicool® brand and the world-wide patents and technology. Fr...

Pharma Active

Pharmaceutical industry has become one of the fastest growing industry. With growth comes the need for experienced professionals and various resources such as clinical trial centres, toxicology centre...

More Information about "A1M Pharma" on BioPortfolio

We have published hundreds of A1M Pharma news stories on BioPortfolio along with dozens of A1M Pharma Clinical Trials and PubMed Articles about A1M Pharma for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of A1M Pharma Companies in our database. You can also find out about relevant A1M Pharma Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Obstetrics and gynaecology
Fertility Menopause Obstetrics & Gynaecology Osteoporosis Women's Health Obstetrics and gynaecology comprises the care of the pregnant woman, her unborn child and the management of diseases specific to women. Most consultant...

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

Renal disease
Chronic kidney disease (CKD), also known as chronic renal disease, is a progressive loss in renal function over a period of months or years. The symptoms of worsening kidney function are non-specific, and might include feeling generally unwell and experi...


Corporate Database Quicklinks



Searches Linking to this Company Record